Non-statin cholesterol drugs on Wellcare Value Script (S4802-163)
Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), California
- Premium
- $5.70/month
- Deductible
- $615.00, doesn't apply to tier 1 and 2
6 of 8 Non-statin cholesterol drugs are covered on this plan. 2 of them require prior authorization.
2 aren't on the formulary (Repatha and Nexlizet).
- 40%Tier 4
- 25%Tier 3
- 25%Tier 3
- $3.00Tier 2
- 40%Tier 4
- 40%Tier 4
Not on the formulary
Repatha, Nexlizet
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.